Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis.

[1]  Jennifer G. Robinson,et al.  Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.

[2]  W. Guan,et al.  Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment: The Multi-Ethnic Study of Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[3]  M. Criqui,et al.  Associations of diabetes mellitus and other cardiovascular disease risk factors with decline in the ankle–brachial index , 2014, Vascular medicine.

[4]  M. Criqui,et al.  Ankle-brachial index, toe-brachial index, and cardiovascular mortality in persons with and without diabetes mellitus. , 2014, Journal of vascular surgery.

[5]  B. Angelin.  Fifty years of lipoprotein(a) – the Magical Mystery Tour continues , 2013, Journal of internal medicine.

[6]  V. Aboyans,et al.  Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. , 2012, Circulation.

[7]  S. Fortmann,et al.  Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients , 2011, Journal of lipids.

[8]  F. Magkos,et al.  Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. , 2011, The Journal of clinical endocrinology and metabolism.

[9]  D. Allison,et al.  Comparing self-reported ethnicity to genetic background measures in the context of the Multi-Ethnic Study of Atherosclerosis (MESA) , 2011, BMC Genetics.

[10]  V. Aboyans,et al.  The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). , 2010, Journal of the American College of Cardiology.

[11]  M. Criqui,et al.  Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease. , 2008, Advances in chronic kidney disease.

[12]  M. Criqui,et al.  Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. , 2008, Journal of the American College of Cardiology.

[13]  V. Thijs,et al.  Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies , 2007, Stroke.

[14]  K. Bailey,et al.  Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations. , 2007, Mayo Clinic proceedings.

[15]  A. Folsom,et al.  The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2006, Journal of the American College of Cardiology.

[16]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[17]  Luigi Ferrucci,et al.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. , 2004, JAMA.

[18]  C. Tseng.  Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan. , 2004, Diabetes care.

[19]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[20]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[21]  Stephen W. K. Cheng,et al.  Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[22]  A. Lee,et al.  Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.

[23]  R. Langer,et al.  Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease , 1992 .

[24]  E. Boerwinkle,et al.  Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.